The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
PAI‐1 in tissue fibrosis
Open accessAbstract
Fibrosis is defined as a fibroproliferative or abnormal fibroblast activation‐related disease. Deregulation of wound healing leads to hyperactivation of fibroblasts and excessive accumulation of extracellular matrix (ECM) proteins in the wound area, the pathological manifestation of fibrosis. The accumulation of excessive levels of collagen in the ECM depends on two factors: an increased rate of collagen synthesis and or decreased rate of collagen degradation by cellular proteolytic activities. The urokinase/tissue type plasminogen activator (uPA/tPA) and plasmin play significant roles in the cellular proteolytic degradation of ECM proteins and the maintenance of tissue homeostasis. The activities of uPA/tPA/plasmin and plasmin‐dependent MMPs rely mostly on the activity of a potent inhibitor of uPA/tPA, plasminogen activator inhibitor‐1 (PAI‐1). Under normal physiologic conditions, PAI‐1 controls the activities of uPA/tPA/plasmin/MMP proteolytic activities and thus maintains the tissue homeostasis. During wound healing, elevated levels of PAI‐1 inhibit uPA/tPA/plasmin and plasmin‐dependent MMP activities, and, thus, help expedite wound healing. In contrast to this scenario, under pathologic conditions, excessive PAI‐1 contributes to excessive accumulation of collagen and other ECM protein in the wound area, and thus preserves scarring. While the level of PAI‐1 is significantly elevated in fibrotic tissues, lack of PAI‐1 protects different organs from fibrosis in response to injury‐related profibrotic signals. Thus, PAI‐1 is implicated in the pathology of fibrosis in different organs including the heart, lung, kidney, liver, and skin. Paradoxically, PAI‐1 deficiency promotes spontaneous cardiac‐selective fibrosis. In this review, we discuss the significance of PAI‐1 in the pathogenesis of fibrosis in multiple organs. J. Cell. Physiol. 227: 493–507, 2012. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244
RetractedBataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Dennler, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3091 · Cited by 1,793
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
Systemic sclerosis: a prototypic multisystem fibrotic disorder
Varga, J., & Abraham, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31139 · Cited by 1,163
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902
The serpin superfamily of proteinase inhibitors: structure, function, and regulation.
Potempa, J., Korzus, E., & Travis, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33954-6 · Cited by 875
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L. E., Schoen, F. J., Kelly, R. A., Werb, Z., Libby, P., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8768 · Cited by 808
The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Molecular basis of renal fibrosis
Eddy, A. A. (2000) · Pediatric Nephrology · doi:10.1007/s004670000461 · Cited by 637
The origin of fibroblasts and mechanism of cardiac fibrosis
Krenning, G., Zeisberg, E. M., & Kalluri, R. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22322 · Cited by 601
Irving, J. A., Pike, R. N., Lesk, A. M., & Whisstock, J. C. (2000) · Genome Research · doi:10.1101/gr.147800 · Cited by 598
TGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
Eitzman, D. T., McCoy, R. D., Zheng, X., Fay, W. P., Shen, T., Ginsburg, D., & Simon, R. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118396 · Cited by 558
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium.
Weber, K. T., Janicki, J. S., Shroff, S. G., Pick, R., Chen, R. M., & Bashey, R. I. (1988) · Circulation Research · doi:10.1161/01.res.62.4.757 · Cited by 556
Hekman, C. M., & Loskutoff, D. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39071-3 · Cited by 547
Doi, S., Zou, Y., Togao, O., Pastor, J. V., John, G. B., Wang, L., Shiizaki, K., Gotschall, R., Schiavi, S., Yorioka, N., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174037 · Cited by 532
Verma, S., Kuliszewski, M. A., Li, S.-H., Szmitko, P. E., Zucco, L., Wang, C.-H., Badiwala, M. V., Mickle, D. A. G., Weisel, R. D., Fedak, P. W. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127577.63323.24 · Cited by 525
Molecular Virology of Hepatitis B Virus
Locarnini, S. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828672 · Cited by 515
TGF-β signaling in vascular fibrosis
RUIZORTEGA, M., RODRIGUEZVITA, J., SANCHEZLOPEZ, E., CARVAJAL, G., & EGIDO, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.008 · Cited by 492
(2004) · Seminars in Liver Disease · doi:10.1055/s-2004-823098 · Cited by 481
Oxidative stress and glutathione in TGF-β-mediated fibrogenesis
Liu, R.-M., & Gaston Pravia, K. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.026 · Cited by 469
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Cesari, M., Pahor, M., & Incalzi, R. A. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00171.x · Cited by 448
Li, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00003-1 · Cited by 434
Yamamoto, T., Takagawa, S., Katayama, I., Yamazaki, K., Hamazaki, Y., Shinkai, H., & Nishioka, K. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00528.x · Cited by 432
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14190 · Cited by 426
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
Petrov, V. V., Fagard, R. H., & Lijnen, P. J. (2002) · Hypertension · doi:10.1161/hy0202.103268 · Cited by 419
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis
Chapman, H. A. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142225 · Cited by 412
Carmeliet, P., Stassen, J. M., Schoonjans, L., Ream, B., van den Oord, J. J., De Mol, M., Mulligan, R. C., & Collen, D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116893 · Cited by 388
Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., Kassiri, Z., Kirshenbaum, L. A., Arnold, M., Khokha, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.643585 · Cited by 383
Liebner, S., Cattelino, A., Gallini, R., Rudini, N., Iurlaro, M., Piccolo, S., & Dejana, E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403050 · Cited by 376
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214190 · Cited by 351
Carmeliet, P., Kieckens, L., Schoonjans, L., Ream, B., van Nuffelen, A., Prendergast, G., Cole, M., Bronson, R., Collen, D., & Mulligan, R. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116892 · Cited by 345
Arciniegas, E., Frid, M. G., Douglas, I. S., & Stenmark, K. R. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00378.2006 · Cited by 341
Biological and clinical aspects of plasminogen activator inhibitor type 2
Kruithof, E., Baker, M., & Bunn, C. (1995) · Blood · doi:10.1182/blood.v86.11.4007.bloodjournal86114007 · Cited by 338
Rohrer, D. K., Desai, K. H., Jasper, J. R., Stevens, M. E., Regula, D. P., Barsh, G. S., Bernstein, D., & Kobilka, B. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7375 · Cited by 310
McCormick, L. L., Zhang, Y., Tootell, E., & Gilliam, A. C. (1999) · PubMed · Cited by 294
Mechanistic connection between inflammation and fibrosis
Lee, S. B., & Kalluri, R. (2010) · Kidney International · doi:10.1038/ki.2010.418 · Cited by 286
Clouthier, D. E., Comerford, S. A., & Hammer, R. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119815 · Cited by 282
The pro‐ or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0552com · Cited by 280
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
Oda, T., Jung, Y. O., Kim, H. S., Cai, X., López-Guisa, J. M., Ikeda, Y., & Eddy, A. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.030002587.x · Cited by 274
Tumor Suppressor Smad4 Is a Transforming Growth Factor β-Inducible DNA Binding Protein
Yingling, J. M., Datto, M. B., Wong, C., Frederick, J. P., Liberati, N. T., & Wang, X.-F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7019 · Cited by 272
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 265
McCormick, L. L., Zhang, Y., Tootell, E., & Gilliam, A. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5693 · Cited by 265
Induction of Cardiac Fibrosis by Aldosterone
Lijnen, P., & Petrov, V. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1129 · Cited by 263
Factors Involved in the Regulation of Type I Collagen Gene Expression: Implication in Fibrosis
Ghosh, A. K. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700502 · Cited by 259
Self-citationFay, W. P., Parker, A. C., Condrey, L. R., & Shapiro, A. D. (1997) · Blood · doi:10.1182/blood.v90.1.204 · Cited by 251
Origins of Cardiac Fibroblasts
Zeisberg, E. M., & Kalluri, R. (2010) · Circulation Research · doi:10.1161/circresaha.110.231910 · Cited by 243
Gressner, A. M. (1996) · PubMed · Cited by 235
Wu, M., Melichian, D. S., Chang, E., Warner-Blankenship, M., Ghosh, A. K., & Varga, J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080574 · Cited by 233
Self-citationGhosh, A. K., Yuan, W., Mori, Y., Chen, S.-J., & Varga, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004709200 · Cited by 225
Self-citationCufí, S., Vazquez-Martin, A., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.22.14048 · Cited by 216
Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
Schleef, R. R., Higgins, D. L., Pillemer, E., & Levitt, L. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114076 · Cited by 210
Taeye, B. D., Smith, L. H., & Vaughan, D. E. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.007 · Cited by 204
Self-citationFibrinolysis: The Key to New Pathogenetic Mechanisms
Zorio, E., Gilabert-Estelles, J., Espana, F., Ramon, L., Cosin, R., & Estelles, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783955455 · Cited by 204
Proteinases in cutaneous wound healing
Toriseva, M., & Kähäri, V.-M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8388-4 · Cited by 203
Ghosh, A. K., Bhattacharyya, S., Lakos, G., Chen, S., Mori, Y., & Varga, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20104 · Cited by 201
Self-citationMaemura, K., de la Monte, S. M., Chin, M. T., Layne, M. D., Hsieh, C.-M., Yet, S.-F., Perrella, M. A., & Lee, M.-E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000629200 · Cited by 196
Wei, J., Ghosh, A. K., Sargent, J. L., Komura, K., Wu, M., Huang, Q.-Q., Jain, M., Whitfield, M. L., Feghali-Bostwick, C., & Varga, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013778 · Cited by 193
Self-citationTissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice
Samad, F., & Loskutoff, D. J. (1996) · Molecular Medicine · doi:10.1007/bf03401641 · Cited by 188
The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
Ghosh, A. K., & Varga, J. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21162 · Cited by 183
Self-citationPirfenidone effectively reverses experimental liver fibrosis
Garcı́a, L., Hernández, I., Sandoval, A., Salazar, A., Garcia, J., Vera, J., Grijalva, G., Muriel, P., Margolin, S., & Armendariz-Borunda, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00272-6 · Cited by 172
Verrecchia, F., Pessah, M., Atfi, A., & Mauviel, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005310200 · Cited by 170
Swaisgood, C. M., French, E. L., Noga, C., Simon, R. H., & Ploplis, V. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64529-4 · Cited by 169
Schoenhard, J. A., Smith, L. H., Painter, C., Eren, M., Johnson, C. H., & Vaughan, D. E. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00051-8 · Cited by 167
Self-citationKaikita, K., Fogo, A. B., Ma, L., Schoenhard, J. A., Brown, N. J., & Vaughan, D. E. (2001) · Circulation · doi:10.1161/hc3301.092803 · Cited by 161
Self-citationMauviel, A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:069 · Cited by 159
Goumans, M.-J., van Zonneveld, A. J., & ten Dijke, P. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.01.001 · Cited by 159
Matsusaka, H., Ide, T., Matsushima, S., Ikeuchi, M., Kubota, T., Sunagawa, K., Kinugawa, S., & Tsutsui, H. (2006) · Hypertension · doi:10.1161/01.hyp.0000208840.30778.00 · Cited by 159
Heymans, S. R. B., Lupu, F., Terclavers, S., Vanwetswinkel, B., Herbert, J., Baker, A. H., Collen, D., Carmeliet, P., & Moons, L. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62228-6 · Cited by 158
Oxidative Stress, Plasminogen Activator Inhibitor 1, and Lung Fibrosis
Liu, R.-M. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1903 · Cited by 153
Ueno, M., Maeno, T., Nomura, M., Aoyagi, K., Matsui, H., Hara, K., Tanaka, T., Iso, T., Suga, T., & Kurabayashi, M. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00146.2010 · Cited by 146
Kunz, C., Pebler, S., Otte, J., & von der Ahe, D. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3710 · Cited by 145
Bauman, K. A., Wettlaufer, S. H., Okunishi, K., Vannella, K. M., Stoolman, J. S., Huang, S. K., Courey, A. J., White, E. S., Hogaboam, C. M., Simon, R. H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38369 · Cited by 144
Genetic Deficiency of Plasminogen Activator Inhibitor-1 Promotes Cardiac Fibrosis in Aged Mice
Ghosh, A. K., Bradham, W. S., Gleaves, L. A., Taeye, B. M. D., Murphy, S. B., Covington, J. W., & Vaughan, D. E. (2010) · Circulation · doi:10.1161/circulationaha.110.955245 · Cited by 138
Self-citationSuppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis
Senoo, T., Hattori, N., Tanimoto, T., Furonaka, M., Ishikawa, N., Fujitaka, K., Haruta, Y., Murai, H., Yokoyama, A., & Kohno, N. (2010) · Thorax · doi:10.1136/thx.2009.119974 · Cited by 135
Epithelial–mesenchymal transition in the skin
Nakamura, M., & TOKURA, Y. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.11.015 · Cited by 134
Margaglione, M., Cappucci, G., Colaizzo, D., Giuliani, N., Vecchione, G., Grandone, E., Pennelli, O., & Minno, G. D. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.152 · Cited by 134
TGF-β : Titan of Lung Fibrogenesis
Yue, X., Shan, B., & A. Lasky, J. (2010) · Current Enzyme Inhibition · doi:10.2174/157340810791233033 · Cited by 130
Ghosh, A. K., Bhattacharyya, S., Wei, J., Kim, S., Barak, Y., Mori, Y., & Varga, J. (2009) · The FASEB Journal · doi:10.1096/fj.08-128736 · Cited by 129
Self-citationTakeshita, K., Hayashi, M., Iino, S., Kondo, T., Inden, Y., Iwase, M., Kojima, T., Hirai, M., Ito, M., Loskutoff, D. J., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63135-5 · Cited by 126
Samarakoon, R., & Higgins, P. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-05-0273 · Cited by 126
Accelerated Skin Wound Healing in Plasminogen Activator Inhibitor-1-Deficient Mice
Chan, J. C. Y., Duszczyszyn, D. A., Castellino, F., & Ploplis, V. A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63015-5 · Cited by 125
Li, Y., Wen, X., Spataro, B. C., Hu, K., Dai, C., & Liu, Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030257 · Cited by 119
Riccio, A., Pedone, P. V., Lund, L. R., Olesen, T., Olsen, H. S., & Andreasen, P. A. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1846 · Cited by 118
Wu, F., & Chakravarti, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.6988 · Cited by 116
Moriwaki, H., Stempien‐Otero, A., Kremen, M., Cozen, A. E., & Dichek, D. A. (2004) · Circulation Research · doi:10.1161/01.res.0000141427.61023.f4 · Cited by 115
He, W., Tan, R., Dai, C., Li, Y., Wang, D., Hao, S., Kahn, M., & Liu, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091256 · Cited by 112
Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor.
Deterding, R. R., Havill, A. M., Yano, T., Middleton, S. C., Jacoby, C., Shannon, J. M., Simonet, W. S., & Mason, R. J. (1997) · PubMed · Cited by 109
Liu, R.-M., Choi, J., Wu, J.-H., Pravia, K. A. G., Lewis, K. M., Brand, J. D., de Mochel, N. S. R., Krzywanski, D. M., Lambeth, J. D., Hagood, J. S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111732 · Cited by 108
Weisberg, A. D., Albornoz, F., Griffin, J. P., Crandall, D. L., Elokdah, H. M., Fogo, A. B., Vaughan, D. E., & Brown, N. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000152356.85791.52 · Cited by 108
Self-citationTGF-β: Titan of Lung Fibrogenesis.
Yue, X., Shan, B., & Lasky, J. A. (2010) · PubMed · doi:10.2174/10067 · Cited by 105
Sisson, T. H., Hattori, N., Xu, Y., & Simon, R. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950016960 · Cited by 104
Samarakoon, R., Higgins, C. E., Higgins, C. E., & Higgins, P. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.12.006 · Cited by 102
Plasminogen activator inhibitor-1: The double-edged sword in apoptosis
Balsara, R. D., & Ploplis, V. A. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-07-0427 · Cited by 102
Wu, Y., Zhang, Q., Ann, D. K., Akhondzadeh, A., Duong, H. S., Messadi, D. V., & Le, A. D. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00200.2003 · Cited by 101
Plasmin(ogen) Promotes Renal Interstitial Fibrosis by Promoting Epithelial-to-Mesenchymal Transition
Zhang, G., Kernan, K. A., Collins, S., Cai, X., López-Guisa, J. M., Degen, J. L., Shvil, Y., & Eddy, A. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080886 · Cited by 99
PAI‐1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA
Wang, H., Zhang, Y., & Heuckeroth, R. O. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.049 · Cited by 98
Ma, L., & Fogo, A. B. (2009) · Frontiers in bioscience · doi:10.2741/3361 · Cited by 98
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
Ma, J., Weisberg, A. D., Griffin, J. P., Vaughan, D. E., Fogo, A. B., & Brown, N. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000201 · Cited by 96
Self-citationY-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ Effects
Dooley, S., Said, H. M., Gressner, A. M., Floege, J., En‐Nia, A., & Mertens, P. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510215200 · Cited by 95
Yano, T., Miura, T., Ikeda, Y., Matsuda, E., Saito, K., Miki, T., Kobayashi, H., Nishino, Y., Ohtani, S., & Shimamoto, K. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.05.004 · Cited by 94
Zhang, Q., Wu, Y., Ann, D. K., Messadi, D. V., Tuan, T., Kelly, A., Bertolami, C. N., & Le, A. D. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12564.x · Cited by 92
Vayalil, P. K., Iles, K. E., Choi, J., Yi, A., Postlethwait, E. M., & Liu, R.-M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00128.2007 · Cited by 92
Tuan, T., Zhu, J., Sun, B., Nichter, L. S., Nimni, M. E., & Laug, W. E. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12338552 · Cited by 90
Induction of epithelial‐mesenchymal transition‐related genes by benzo[a]pyrene in lung cancer cells
Yoshino, I., Kometani, T., Shoji, F., Osoegawa, A., Ohba, T., Kouso, H., Takenaka, T., Yohena, T., & Maehara, Y. (2007) · Cancer · doi:10.1002/cncr.22728 · Cited by 85
Pandey, M., Loskutoff, D. J., & Samad, F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3459fje · Cited by 84
Kaimori, A., Potter, J. J., Choti, M. A., Ding, Z., Mezey, E., & Koteish, A. A. (2010) · Hepatology · doi:10.1002/hep.23765 · Cited by 84
Hattori, N., Mizuno, S., Yoshida, Y., Chin, K., Mishima, M., Sisson, T. H., Simon, R. H., Nakamura, T., & Miyake, M. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63196-3 · Cited by 81
Jansen, P. L. M. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00001 · Cited by 81
Kitamura, M., Shimizu, M., Ino, H., Okeie, K., Yamaguchi, M., Fujino, N., Mabuchi, H., & Nakanishi, I. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240413 · Cited by 78
Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis
Zhang, G., Cheng, T., Luan, Q., Liao, T., Nie, C., Zheng, X. S., Xie, X. G., & Gao, W. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10130.x · Cited by 77
The Tumor Suppressor p53 Abrogates Smad-dependent Collagen Gene Induction in Mesenchymal Cells
Ghosh, A. K., Bhattacharyya, S., & Varga, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403477200 · Cited by 74
Self-citationHigashi, K., Inagaki, Y., Suzuki, N., Mitsui, S., Mauviel, A., Kaneko, H., & Nakatsuka, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208724200 · Cited by 74
Impaired endothelial function in C-reactive protein overexpressing mice
Teoh, H., Quan, A., Lovren, F., Wang, G., Tirgari, S., Szmitko, P. E., Szalai, A. J., Ward, M. E., & Verma, S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.034 · Cited by 74
Recent advances in fibroblast signaling and biology in scleroderma
Pannu, J., & Trojanowska, M. (2004) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000137894.63091.1a · Cited by 73
Iraburu, M. J., Domínguez-Rosales, J. A., Fontana, L., Auster, A. S., García–Trevijano, E. R., Covarrubias-Pinedo, A., Rivas, A., Greenwel, P., & Rojkind, M. (2000) · Hepatology · doi:10.1053/he.2000.5981 · Cited by 71
Xu, Z., Castellino, F., & Ploplis, V. A. (2009) · Blood · doi:10.1182/blood-2009-09-244962 · Cited by 71
The Impact of the Fibrinolytic System on the Risk of Venous and Arterial Thrombosis
Meltzer, M. E., Doggen, C. J. M., de Groot, P. G., Rosendaal, F. R., & Lisman, T. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1234142 · Cited by 71
Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse Skin
Asano, Y., Markiewicz, M., Kubo, M., Szalai, G., Watson, D. K., & Trojanowska, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01278-08 · Cited by 70
Horton, M. R., Olman, M. A., Bao, C., White, K. E., Choi, A. M. K., Chin, B. Y., Noble, P. W., & Lowenstein, C. J. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.4.l707 · Cited by 69
Plasminogen Activator Inhibitor–1 Impairs Alveolar Epithelial Repair by Binding to Vitronectin
Lazar, M. H., Christensen, P. J., Du, M., Yu, B., Subbotina, N. M., Hanson, K. E., Hansen, J. M., White, E. S., Simon, R. H., & Sisson, T. H. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0025oc · Cited by 67
BMP-7 Does Not Protect against Bleomycin-Induced Lung or Skin Fibrosis
Murray, L. A., Hackett, T., Warner, S., Shaheen, F., Argentieri, R. L., Dudas, P. L., Farrell, F. X., & Knight, D. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004039 · Cited by 65
Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes
Lira, F. S., Neto, J. C. R., Lima‐Silva, A. E., Souza, H. A., Caperuto, É. C., Seelaender, M. C. L., Dâmaso, A. R., Oyama, L. M., & dos Santos, R. V. T. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-7 · Cited by 63
Gramley, F., Lorenzen, J., Plisienė, J., Rakauskas, M., Benetis, R., Schmid, M., Autschbach, R., Knackstedt, C., Schimpf, T., Mischke, K., et al. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00906.x · Cited by 62
Chanda, D., Lee, C. H., Kim, Y.-H., Noh, J., Kim, D., Park, J.-H., Hwang, J. H., Lee, M., Jeong, K.-H., Lee, I., et al. (2009) · Hepatology · doi:10.1002/hep.23049 · Cited by 62
Das, F., Ghosh‐Choudhury, N., Venkatesan, B. A., Li, X., Mahimainathan, L., & Choudhury, G. G. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21236 · Cited by 61
Denton, C. P., Lindahl, G. E., Khan, K., Shiwen, X., Ong, V. H., Gaspar, N. J., Lazaridis, K., Edwards, D. R., Leask, A., Eastwood, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413134200 · Cited by 61
Plasminogen Activator Inhibitor-1 and the Circadian Clock in Metabolic Disorders
Oishi, K. (2009) · Clinical and Experimental Hypertension · doi:10.1080/10641960902822468 · Cited by 60
Zhang, Q., Wu, Y., Chau, C. H., Ann, D. K., Bertolami, C. N., & Le, A. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10452 · Cited by 59
Bitterman, P. B., & Henke, C. A. (1991) · CHEST Journal · doi:10.1378/chest.99.3_supplement.81s · Cited by 59
The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1
van der Bom, J. G., Bots, M. L., Haverkate, F., Kluft, C., & Grobbee, D. E. (2003) · Blood · doi:10.1182/blood-2002-07-2181 · Cited by 58
Chuang-Tsai, S., Sisson, T. H., Hattori, N., Tsai, C. G., Subbotina, N. M., Hanson, K. E., & Simon, R. H. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63674-7 · Cited by 57
Hertig, A., Berrou, J., Allory, Y., Breton, L., Commo, F., de Beauregard, M.-A. C., Carmeliet, P., & Rondeau, É. (2003) · The FASEB Journal · doi:10.1096/fj.03-0084fje · Cited by 57
Ploplis, V. A., Balsara, R. D., Sandoval-Cooper, M. J., Yin, Z. J., Batten, J., Modi, N., Gadoua, D., Donahue, D. L., Martin, J. A., & Castellino, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307297200 · Cited by 55
Kortlever, R. M., Nijwening, J. H., & Bernards, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803341200 · Cited by 55
España, F., Estellés, A., Fernández, P. J., Gilabert, J., Sánchez-Cuenca, J. M., & Griffin, J. H. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649712 · Cited by 53
Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts
Ihn, H., Yamane, K., Asano, Y., Jinnin, M., & Tamaki, K. (2005) · Rheumatology · doi:10.1093/rheumatology/kei124 · Cited by 53
Andrew, A. S., Klei, L. R., & Barchowsky, A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.3.l607 · Cited by 50
Kishore, P., Li, W., Tonelli, J., Lee, D.-E., Koppaka, S., Zhang, K., Lin, Y., Kehlenbrink, S., Scherer, P. E., & Hawkins, M. A. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000292 · Cited by 49
Gong, W., Roth, S., Michel, K., & Gressner, A. M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70488-3 · Cited by 49
Role of caveolin-1 in the pathogenesis of tissue fibrosis by keloid-derived fibroblasts in vitro
Zhang, G.-Y., Yu, Q., Cheng, T., Liao, T., Nie, C., Wang, A., Zheng, X. S., Xie, X.-G., Albers, A. E., & Gao, W. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10111.x · Cited by 44
Pedroja, B. S., Kang, L. E., Imas, A., Carmeliet, P., & Bernstein, A. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018804 · Cited by 44
Nagamine, Y. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-05-0294 · Cited by 43
Ghosh, A. K., Wei, J., Wu, M., & Varga, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.014 · Cited by 43
Self-citationMorning Resistance to Thrombolytic Therapy
Braunwald, E. (1995) · Circulation · doi:10.1161/01.cir.91.5.1604 · Cited by 43
Plasminogen activator inhibitor 1 is an intracellular inhibitor of furin proprotein convertase
Bernot, D., Stalin, J., Stocker, P., Bonardo, B., Scroyen, I., Alessi, M., & Peiretti, F. (2011) · Journal of Cell Science · doi:10.1242/jcs.079889 · Cited by 43
Song, C. Y., Kim, B. C., Hong, H. K., & Lee, H. S. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00271.x · Cited by 42
Involvement of bone-marrow-derived cells in kidney fibrosis
Wada, T., Sakai, N., Sakai, Y., Matsushima, K., Kaneko, S., & Furuichi, K. (2010) · Clinical and Experimental Nephrology · doi:10.1007/s10157-010-0372-2 · Cited by 42
Chen, Y. Q., Sloan‐Lancaster, J., Berg, D. T., Richardson, M., Grinnell, B. W., & Tseng-Crank, J. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616763 · Cited by 39
Plasminogen activators and plasminogen activator inhibitors in endometriosis
Gilabert–Estellés, J. (2005) · Frontiers in bioscience · doi:10.2741/1609 · Cited by 38
Higgins, P. J., Slack, J. K., Diegelmann, R. F., & Staiano‐Coico, L. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4466 · Cited by 38
Lee, E. K., Lee, Y. S., Han, I.-O., & Park, S. H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.121 · Cited by 38
Ghosh, A. K., Bhattacharyya, S., Mori, Y., & Varga, J. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20559 · Cited by 37
Self-citationTuan, T., Hwu, P., Ho, W., Yiu, P., Chang, R., Wysocki, A. B., & Benya, P. D. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080272 · Cited by 36
Bueno‐Topete, M. R., Daneri‐Navarro, A., & Armendáriz‐Borunda, J. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80123-3 · Cited by 36
Murakami, M., Ikeda, T., Saito, T., Ogawa, K., Nishino, Y., Nakaya, K., & Funaba, M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.010 · Cited by 33
A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart
Zaman, A. K. M. T., French, C. J., Schneider, D. J., & Sobel, B. E. (2009) · Experimental Biology and Medicine · doi:10.3181/0811-rm-321 · Cited by 33
Li, W., Huang, E. Y., Dudáš, M., Kaartinen, V., Warburton, D., & Tuan, T. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00158.x · Cited by 32
Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats
Serrano, R., Barrenetxe, J., Orbe, J., Rodríguez, J. A., Gallardo, N., Martı́nez, C., Andrés, A., & Páramo, J. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00093.2009 · Cited by 31
Andrew, A. S., Klei, L. R., & Barchowsky, A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.3.l616 · Cited by 27
4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries
Schrempf, M. C., Erl, A., Mueller, J. C., Hoppmann, P., Schömig, A., Kastrati, A., & Koch, W. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-10-0702 · Cited by 27
Eren, M., Painter, C., Gleaves, L. A., Schoenhard, J. A., Atkinson, J. B., Brown, N. J., & Vaughan, D. E. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00437.x · Cited by 26
Self-citationPPARγ Agonist and Angiotensin II Receptor Antagonist Ameliorate Renal Tubulointerstitial Fibrosis
Han, J.-Y., Kim, Y.-J., Kim, L., Choi, S. J., Park, I.-S., Kim, J. M., Chu, Y. C., & Cha, D.-R. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.1.35 · Cited by 26
Li, G., Heaton, J. H., & GELEHRTER, T. D. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0145 · Cited by 24
Matsushita, M., Yamamoto, T., & Nishioka, K. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02718.x · Cited by 24
Expression of the Fibrinolytic Components in Endometriosis
Gilabert–Estellés, J., Ramón, L., España, F., Gilabert, J., Castelló, R., & Estellés, A. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093556 · Cited by 23
Huang, E. Y., Wu, H., Island, E. R., Chong, S., Warburton, D., Anderson, K. D., & Tuan, T. (2002) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2002.t01-1-10608.x · Cited by 23
Farivar, R. S., Crawford, D. C., Chobanian, A. V., & Brecher, P. I. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.809 · Cited by 22
Böttiger, C., Koch, W., Lahn, C., Mehilli, J., von Beckerath, N., Schömig, A., & Kastrati, A. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00363-6 · Cited by 21
Ernst, S., Leugers, A., Willecke, F., Sobel, B. E., Bode, C., Nordt, T. K., & Zirlik, A. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-03-0164 · Cited by 14
Fintha, A., Sebe, A., Masszi, A., Terebessy, T., Húszár, T., Rosivall, L., & Mucsi, I. (2007) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.94.2007.1-2.4 · Cited by 11
Masuda, Y., Emoto, N., Nonaka, H., Yagita, K., Todo, T., Okamura, H., Yokoyama, M., & Hirata, K. (2009) · PubMed · doi:10.24546/81001294 · Cited by 9
Cited by
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874
An integrated cell atlas of the lung in health and disease
Sikkema, L., Ramírez-Suástegui, C., Strobl, D. C., Gillett, T. E., Zappia, L., Madissoon, E., Markov, N. S., Zaragosi, L.-E., Ji, Y., Ansari, M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02327-2 · Cited by 854
Targeting metabolic dysregulation for fibrosis therapy
Zhao, X., Kwan, J. Y. Y., Yip, K., Liu, P. P., & Liu, F.-F. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0040-5 · Cited by 513
Greaves, N. S., Ashcroft, K. J., Baguneid, M., & Bayat, A. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.07.008 · Cited by 478
Multi-organ proteomic landscape of COVID-19 autopsies
Nie, X., Qian, L., Sun, R., Huang, B., Dong, X., Xiao, Q., Zhang, Q., Lu, T., Yue, L., Chen, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.004 · Cited by 408
Metadata
- Authors
- Ghosh, A. K., & Vaughan, D. E.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2011-11-23
- Volume
- 227
- Issue
- 2
- Pages
- 493-507
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2081415617
- Cited by
- 679
- References
- 181
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.